Dental Bone Graft Substitute Market

A dental bone graft is a surgical technique where artificial or real bone is used to repair a lost jawbone. This surgery is often performed to enhance the aesthetics of the smile or to restore oral function.

A major element driving the growth of the dental bone graft market is the increasing frequency of periodontal diseases and other illnesses that result in jawbone loss. In addition, the rising popularity of cosmetic dentistry operations requiring dental implants also contributes to market expansion. Increasing awareness of the advantages of dental implants and the availability of sophisticated implant technologies are anticipated to further stimulate market expansion over the forecast period.

A dental bone graft augments the jawbone's volume and density in locations where bone loss has occurred. The bone transplant material can come from your own body (autogenous), a human tissue bank (allograft), or an animal tissue bank (xenograft)me from your own body (autogenous), a human tissue bank (allograft), or an animal tissue bank (xenograft). In some cases, synthetic bone graft material may be used (alloplastic).

According to a new analysis by Grand View Research, Inc., the global market for dental bone grafts is projected to reach $XX billion by 2031. A XX% CAGR is projected for the market over the forecast period. The demand for dental bone grafts is anticipated to increase throughout the forecast period due to the rising incidence of periodontal disorders and tooth loss.

Dentsply Sirona, Danaher Corporation, Johnson & Johnson, Medtronic, Zimmer Biomet, BioHorizons IPH, Inc., RTI Surgical Holding Inc., Straumann Group, Lifenet Health, and Dentium are some of the leading participants in the dental bone graft market.